Sensabues collectorSensabues AB offers a non-intrusive biomatrix ideal for drug, metabolite and biomarker testing. This is a newly discovered, novel and proprietary procedure for the collection, detection and identification of non-volatile substances in blood using exhaled breath. These can be exogenous substances, such as performance enhancing drugs (stimulants) in sports, drugs of abuse (narcotics / cannabinoids) and therapeutic drugs (antibiotics). Also, these can be a wide range of endogenous substances associated with the study of metabolomics and determination of biomarkers.

Using existing lab-based mass spectrometry instrumentation, this exhaled breath based biomatrix platform, ExaBreath® (EB), is transforming drug detection, health monitoring and medical diagnostics for:

  • anti-doping/performance enhancing drugs control in sports
  • drug prevention programs in sports
  • drugs of abuse testing
  • therapeutic drug monitoring
  • biomarker detection
  • metabolomics analysis

EB is achieving this by:

  • lowering the cost of sample collection
  • reducing specimen sampling collection time and complexity
  • making specimen sampling collection more convenient and less intrusive
  • affording more protection for a donor’s right-to-privacy
  • increasing the acceptability and frequency of sample collection
  • enabling new types of collection procedures